The scientists have developed a bio-functional thermogel, a type of synthetic polymer, to prevent retinal scarring caused by failed retinal detachment repair surgery. Proliferative vitreoretinopathy (PVR) occurs when the retinal scarring prevents the retina from healing and falling back into place, and accounts for more than 75 per cent of failed retinal detachment surgeries, and may result in vision loss or blindness if left unrepaired.
Current treatment options for PVR are limited to surgical removal of these scar membranes with guarded visual recovery. This work highlights the potential of using synthetic polymers alone to modulate cellular behaviour and for the first time, offers a novel thermogel-based therapy to prevent retinal scarring.
The research team demonstrated that a bio-functional thermogel alone is able to prevent retinal scarring in a pre-clinical model that mimics human disease. Using retinal cells, the team observed that the thermogel prevented the development of the scar membranes by modulating cellular behaviours such as proliferation and migration.
This is mediated primarily via clathrin-dependent internalisation of polymeric micelles, downstream suppression of canonical EMT transcription factors, reduction of RPE cell hyper-proliferation and migration. Using genome-wide transcriptomic analysis to profile cellular gene expression, they revealed that the thermogel activated a protein called nuclear factor erythroid 2-related factor 2 (NRF2), to kickstart a series of chemical reactions to prevent scarring.
“Our study offers insight into how synthetic polymers no longer function merely as inert drug carriers. It challenges the conventional belief that the use of a small molecule drug is always required to achieve a therapeutic effect. Beyond ophthalmology, this unique bio-functionality of the thermogel can also be applied to other diseases such as orthopaedics where intra-articular joint scarring might be a problem,” said the Senior Principal Investigator.
“When we first developed this bio-functional thermogel at IMRE, we realised it was a significant step forward in developing next-generation biodegradable polymers. Its ability to mimic and substitute vitreous given the biocompatibility of the material, makes it useful for many other biomedical applications,” said another author.
The thermogel is currently being commercialised by Vitreogel Innovations Inc, an A*STAR spin-off that focuses on developing polymer-based therapeutics for ophthalmology indications. Vitreogel Innovations Inc is an ISO 13485 (Medical Device Quality Systems) accredited company that is generating a clinical grade version of the polymer for first-in-man clinical trials.
Building on this work, the team will continue to test the safety and efficacy of this polymer for retinal detachment repair and PVR prevention using additional pre-clinical disease models. Through their work, the team aims to engineer the next generation of polymers with targeted chemical modifications to elicit specific cellular behaviours, and identify alternative applications of the thermogel beyond ophthalmology.
https://www.nature.com/articles/s41467-022-30474-6
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fa-bio-functional&filter=22
A novel therapy using unique thermogel prevents retinal scarring
- 1,146 views
- Added
Latest News
Immune cells identified as…
By newseditor
Posted 28 Mar
TB blood test which could d…
By newseditor
Posted 27 Mar
Propionate supplementation…
By newseditor
Posted 27 Mar
Role of human Kallistatin i…
By newseditor
Posted 26 Mar
Addressing both flu and COV…
By newseditor
Posted 26 Mar
Other Top Stories
Three dimensional organization of DNA determines cell type differen…
Read more
Muscle fibers role in worm regeneration!
Read more
Heart repair using large cardiopatch!
Read more
Hlf gene modulates hematopoietic cell lineage specificity
Read more
Can loss of smell be repaired?
Read more
Protocols
All-optical presynaptic pla…
By newseditor
Posted 23 Mar
Epigenomic tomography for p…
By newseditor
Posted 20 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Profiling native pulmonary…
By newseditor
Posted 08 Mar
Publications
BHLHE40/41 regulate microgl…
By newseditor
Posted 28 Mar
Balancing neuronal activity…
By newseditor
Posted 28 Mar
OSBP-mediated PI(4)P-choles…
By newseditor
Posted 28 Mar
Integrated plasma proteomic…
By newseditor
Posted 27 Mar
APP antisense oligonucleoti…
By newseditor
Posted 27 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar